Registration has now opened for Oxford Global’s 2nd Annual Drug Discovery USA Congress 2015
7 July 2015 | By Oxford Global
The 2nd Annual Drug Discovery USA Congress is taking place on the 29th & 30th of October 2015 in Boston, USA...
List view / Grid view
7 July 2015 | By Oxford Global
The 2nd Annual Drug Discovery USA Congress is taking place on the 29th & 30th of October 2015 in Boston, USA...
6 July 2015 | By Oxford Global
Oxford Global Conferences are delighted to announce the 2nd Annual Stem Cell Congress with our co-located Cell & Gene Therapy is taking place on the 9th & 10th of November in London, UK..
3 July 2015 | By Victoria White
New research suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective flu vaccines...
2 July 2015 | By Victoria White
Biogen and AGTC have announced a broad collaboration and license agreement to develop gene therapies for multiple ophthalmic diseases...
2 July 2015 | By Victoria White
Scientists have pioneered the use electron cryo-microscopy (cryo-EM) to picture in exquisite detail one of the central proteins of life...
1 July 2015 | By Victoria White
A European Nano-Characterisation Laboratory has launched with the aim of reaching a level of international excellence in nanomedicine characterisation...
1 July 2015 | By Victoria White
A team researchers has engineered yeast cells (Saccharomyces cerevisiae) that can "talk" to one another, using a versatile plant hormone called auxin...
30 June 2015 | By Victoria White
Scientists have unravelled a key process in the bacterium that causes TB, potentially paving the way for new antibiotics to fight the disease...
26 June 2015 | By Victoria White
A new study by scientists from the Scripps Research Institute reveals a key part of the Ebola virus life cycle at a higher resolution than ever before...
26 June 2015 | By Victoria White
Siemens and BioNTech will work together on the construction of a fully automated and digitalised production site for BioNTech's personalised cancer vaccines...
25 June 2015 | By Victoria White
Bristol-Myers Squibb Company has announced important next steps in the evolution of the Company’s R&D organisation...
24 June 2015 | By Victoria White
AYOXXA and Grünenthal have completed a research collaboration to validate detection limits for a biomarker based on AYOXXA’s proprietary technology platform...
Find out about the science behind Affimers - including why Affimers are superior to antibodies and details about our custom Affimer process...
Find out more about the applications of Affimers, including how Affimers can be used in the development of therapeutics...
22 June 2015 | By Victoria White
The Dementia Consortium is funding a new project to target the immune system in the hunt for new treatments for Alzheimer's disease...